Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity

The inverse correlation observed between Alzheimer’s disease (AD) and cancer has prompted us to look for cholinesterase-inhibiting activity in phenothiazine derivatives that possess anticancer properties. With the use of in silico and in vitro screening methods, our study found a new biological acti...

Full description

Bibliographic Details
Main Authors: Jakub Jończyk, Justyna Godyń, Ewelina Stawarska, Beata Morak-Młodawska, Małgorzata Jeleń, Krystian Pluta, Barbara Malawska
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/11/2604
_version_ 1797566213133434880
author Jakub Jończyk
Justyna Godyń
Ewelina Stawarska
Beata Morak-Młodawska
Małgorzata Jeleń
Krystian Pluta
Barbara Malawska
author_facet Jakub Jończyk
Justyna Godyń
Ewelina Stawarska
Beata Morak-Młodawska
Małgorzata Jeleń
Krystian Pluta
Barbara Malawska
author_sort Jakub Jończyk
collection DOAJ
description The inverse correlation observed between Alzheimer’s disease (AD) and cancer has prompted us to look for cholinesterase-inhibiting activity in phenothiazine derivatives that possess anticancer properties. With the use of in silico and in vitro screening methods, our study found a new biological activity in anticancer polycyclic, tricyclic, and tetracyclic compounds. The virtual screening of a library of 120 ligands, which are the derivatives of azaphenothiazine, led to the identification of 25 compounds that can act as potential inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). Biological assays revealed the presence of selective inhibitors of <i>ee</i>AChE (<i>electric eel</i> AChE) or <i>eq</i>BuChE (<i>equine serum</i> BuChE) and nonselective inhibitors of both enzymes among the tested compounds. Their potencies against <i>ee</i>AChE were in a submicromolar-to-micromolar range with IC<sub>50</sub> values from 0.78 to 19.32 μM, while their IC<sub>50</sub> values against <i>eq</i>BuChE ranged from 0.46 to 10.38 μM. The most potent among the compounds tested was the tetracyclic derivative, 6-(4-diethylaminobut-2-ynyl)-9-methylthioquinobenzothiazine <b>24</b>, which was capable of inhibiting both enzymes. 9-Fluoro-6-(1-piperidylethyl)quinobenzothiazine <b>23</b> was found to act as a selective inhibitor of <i>eq</i>BuChE with an IC<sub>50</sub> value of 0.46 μM. Compounds with such a dual antitumor and cholinesterase-inhibitory activity can be considered as a valuable combination for the treatment of both cancer and AD prevention. The results presented in this study might open new directions of research on the group of tricyclic phenothiazine derivatives.
first_indexed 2024-03-10T19:23:30Z
format Article
id doaj.art-1a61fca694ef43b1a61990b7f12842f8
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T19:23:30Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-1a61fca694ef43b1a61990b7f12842f82023-11-20T02:45:38ZengMDPI AGMolecules1420-30492020-06-012511260410.3390/molecules25112604Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting ActivityJakub Jończyk0Justyna Godyń1Ewelina Stawarska2Beata Morak-Młodawska3Małgorzata Jeleń4Krystian Pluta5Barbara Malawska6Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, PolandDepartment of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, PolandDepartment of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, PolandDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, The Medical University of Silesia in Katowice Jagiellońska 4, 41-200 Sosnowiec, PolandDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, The Medical University of Silesia in Katowice Jagiellońska 4, 41-200 Sosnowiec, PolandDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, The Medical University of Silesia in Katowice Jagiellońska 4, 41-200 Sosnowiec, PolandDepartment of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, PolandThe inverse correlation observed between Alzheimer’s disease (AD) and cancer has prompted us to look for cholinesterase-inhibiting activity in phenothiazine derivatives that possess anticancer properties. With the use of in silico and in vitro screening methods, our study found a new biological activity in anticancer polycyclic, tricyclic, and tetracyclic compounds. The virtual screening of a library of 120 ligands, which are the derivatives of azaphenothiazine, led to the identification of 25 compounds that can act as potential inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). Biological assays revealed the presence of selective inhibitors of <i>ee</i>AChE (<i>electric eel</i> AChE) or <i>eq</i>BuChE (<i>equine serum</i> BuChE) and nonselective inhibitors of both enzymes among the tested compounds. Their potencies against <i>ee</i>AChE were in a submicromolar-to-micromolar range with IC<sub>50</sub> values from 0.78 to 19.32 μM, while their IC<sub>50</sub> values against <i>eq</i>BuChE ranged from 0.46 to 10.38 μM. The most potent among the compounds tested was the tetracyclic derivative, 6-(4-diethylaminobut-2-ynyl)-9-methylthioquinobenzothiazine <b>24</b>, which was capable of inhibiting both enzymes. 9-Fluoro-6-(1-piperidylethyl)quinobenzothiazine <b>23</b> was found to act as a selective inhibitor of <i>eq</i>BuChE with an IC<sub>50</sub> value of 0.46 μM. Compounds with such a dual antitumor and cholinesterase-inhibitory activity can be considered as a valuable combination for the treatment of both cancer and AD prevention. The results presented in this study might open new directions of research on the group of tricyclic phenothiazine derivatives.https://www.mdpi.com/1420-3049/25/11/2604cholinesterase inhibitorsvirtual screeningAlzheimer’s diseaseanticancer agentsdipyridothiazinesquinobenzothiazine
spellingShingle Jakub Jończyk
Justyna Godyń
Ewelina Stawarska
Beata Morak-Młodawska
Małgorzata Jeleń
Krystian Pluta
Barbara Malawska
Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
Molecules
cholinesterase inhibitors
virtual screening
Alzheimer’s disease
anticancer agents
dipyridothiazines
quinobenzothiazine
title Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
title_full Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
title_fullStr Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
title_full_unstemmed Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
title_short Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
title_sort dual action of dipyridothiazine and quinobenzothiazine derivatives anticancer and cholinesterase inhibiting activity
topic cholinesterase inhibitors
virtual screening
Alzheimer’s disease
anticancer agents
dipyridothiazines
quinobenzothiazine
url https://www.mdpi.com/1420-3049/25/11/2604
work_keys_str_mv AT jakubjonczyk dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity
AT justynagodyn dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity
AT ewelinastawarska dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity
AT beatamorakmłodawska dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity
AT małgorzatajelen dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity
AT krystianpluta dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity
AT barbaramalawska dualactionofdipyridothiazineandquinobenzothiazinederivativesanticancerandcholinesteraseinhibitingactivity